Icahn Capital's George Hebard Named as Director on Enzon Pharma (ENZN) Board

Article Stock Quotes (1) Comments (0)

In a 13D filing after the close on Enzon Pharma (Nasdaq: ENZN), Carl Icahn disclosed the company's Board named George Hebard as a director. Hebard is a managing director at Icahn Capital LP.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Icahn Proposes Dell (DELL) Start Offer for 1.1B Shares at $14/Share
• Columbia Pacific Approached Vitesse Semi (VTSS) About Possible Takeover
• Nova Measuring (NVMI) CEO Gabi Seligsohn Resigns

Create E-mail Alert Related Categories

13Ds, Management Changes

Related Entities

Carl Icahn, 13D

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?